CURRENT LIQUID BIOPSY PUBLICATIONS
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
-
2026
- Fabi A, Giordani E, Ricciardi E, Arpino G, Allegretti M, Ferretti G, Omarini C, Zambelli A, Mandoj C, Botticelli A, Bria E, Gori S, Carbognin L, Paris I, Scambia G, Cognetti F, Giannarelli D, Giacomini P; Gruppo Italiano Mammella (GIM). Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer. J Exp Clin Cancer Res. 2026 Jan 20. Epub ahead of print. https://doi.org/10.1186/s13046-025-03605-2 .
- Zandra C. Deans, Jennifer Fairley, Simon J. Patton, Claudia Koch, Rodrigo A. Toledo, Klaus Pantel, Patrizio Giacomini, Ed Schuuring, Ellen Heitzer, Simon A. Joosse. Reference materials and external quality assessment for liquid biopsy assays: Expert opinions from the European Liquid Biopsy Society ctDNA workshop. Cancer Treatment and Research Communications. Volume 47. 2026. 101151. ISSN 2468-2942. doi: https://doi.org/10.1016/j.ctarc.2026.101151 .
-
2025
de Jager, V. D., et al. Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA Workshop. EBioMedicine, 114, 105636. 2025. https://doi.org/10.1016/j.ebiom.2025.105636
Pantel, K., Alix-Panabières, C. Minimal residual disease as a target for liquid biopsy in patients with solid tumours. Nat Rev Clin Oncol 22, 65–77, 2025; https://doi.org/10.1038/s41571-024-00967-y
Alix-Panabières, C., Pantel, K., Advances in liquid biopsy: From exploration to practical application, Cancer Cell, Volume 43, Issue 2, 2025, Pages 161-165, ISSN 1535-6108; https://doi.org/10.1016/j.ccell.2024.11.009
Pantel, K., et al. Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS). J Exp Clin Cancer Res 44, 156, 2025; https://doi.org/10.1186/s13046-025-03398-4
Ilié M, Malapelle U, Alix-Panabières C, Andersen CL, Chlebowski S, Lake V, Lacoux C, Lespinet-Fabre V, Bordone O, Heeke S, Bontoux C, Heitzer E, Pantel K, Hofman P. Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology. Mol Oncol. 2025 Nov 14. PMID: 41235697. Epub ahead of print. https://doi.org/10.1002/1878-0261.70163
-
2024
Mark Sementsov et. al. - Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma; EMBO Mol Med, 2024, 16, 1560 - 1578; https://doi.org/10.1038/s44321-024-00082-6
Tanja Fehm et. al. - Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial; Clinical Chemistry, 2024, 70, 1, 307-318; https://doi.org/10.1093/clinchem/hvad144
Richard Drexler et. al. - A prognostic neural epigenetic signature in high-grade glioma; Nature Medicine, 2024, 30, 1622–1635; https://doi.org/10.1038/s41591-024-02969-w
-
2023
Paul van der Leest et al. – Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients; International Journal of Molecular Sciences, 2023, 24, 13390; https://doi.org/10.3390/ijms241713390 (Link zur Publikation: https://www.mdpi.com/1422-0067/24/17/13390 )
Heidrich et al. – Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors; Cancer Metastasis Rev (2023). https://doi.org/10.1007/s10555-022-10075-x (Link zur Publikation: https://link.springer.com/article/10.1007/s10555-022-10075-x )
Wankhede et al. – Circulating Tumor Cells as a Predictive Biomarker in Resectable Lung Cancer: A Systematic Review and Meta-Analysis; Cancers 2022, 14(24), 6112; https://doi.org/10.3390/cancers14246112 (Link zur Publikation: https://www.mdpi.com/2072-6694/14/24/6112 )
-
2022
J. Pascual et. al. - ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group; Annals of Oncology, 2022, 33, 8, 750-768; https://doi.org/10.1016/j.annonc.2022.05.520 (Link zur Publikation: https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2822%2901721-5
-
2021
Liquid Biopsy: From Discovery to Clinical Application
Interesting new review by ELBS pioneers Dr. Catherine Alix-Panabieres and Prof. Dr. med. Klaus Pantel on bridging the gap between state-of-the-art research and the clinical application of liquid biopsies.
cancerdiscovery.aacrjournals.org/content/11/4/858